This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.
This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.
This talk provides a practical update on how wearable devices detect atrial fibrillation (AF), and how to interpret alerts in a clinical context.
It offers information on what steps to take when a patient presents with a watch/device-detected AF episode, in the context of the 2024 ESC Guidelines on AF.
Date & Time: 26th June 2025, 12:00-12:30pm
Speaker: Dr Emma Svennberg
Dr. Emma Svennberg is an Assistant Professor, Electrophysiologist, and Head of Specialty Training at the Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Her primary research interests focus on atrial fibrillation (AF) screening, particularly systematic approaches, where she has played a key role in the large population-based screening studies STROKESTOP I & II.
For more information:
Reading Time
1 mins